Roche announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for its investigational oral medicine balovaptan (previously known as RG7314), a vasopressin 1a (V1a) receptor antagonist for individuals with autism spectrum disorder (ASD).

IBM Security today released a global study examining consumer perspectives around digital identity and authentication, which found that people now prioritize security over convenience when logging into applications and devices.

DENSO Corporation today announced that it will undertake a demonstration project aimed at training system integrators who can handle production and failure analysis equipment in Thailand by using a showcase production line for next-generation lean automation

ADB's Board of Directors has approved a $21.3 million grant to help upgrade the Aiwo boat harbor in Nauru, which will make it the country’s first fully functioning international port.

"On this planet, the wind blows the wrong way."